NAPATECH And TOYOTA CAETANO On The List Of Winners And Losers Of Thursday’s Euronext Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are NAPATECH, MOLTEN VENTURES, and HEXAGON COMPOSITES.

Financial Asset Price Change Updated (EST)
NAPATECH (NAPA.OL) 29.40 28.95% 2024-05-09 12:41:14
MOLTEN VENTURES (GRW.IR) 3.38 14.19% 2024-05-09 12:22:46
HEXAGON COMPOSITES (HEX.OL) 21.35 12.37% 2024-05-09 12:40:24
ODFJELL SER. B (ODFB.OL) 165.50 9.24% 2024-05-09 12:41:49
ODFJELL TECHNOLOGY (OTL.OL) 65.00 7.26% 2024-05-09 12:41:51
AFFLUENT MEDICAL (AFME.PA) 1.78 7.23% 2024-05-09 12:45:09
POLIGHT (PLT.OL) 2.61 6.75% 2024-05-09 12:42:19
IEP INVEST (IEP.BR) 5.70 6.54% 2024-05-09 12:20:14
DNO (DNO.OL) 11.17 6.38% 2024-05-09 12:25:29
PROTECTOR FORSIKRG (PROT.OL) 241.50 5.92% 2024-05-09 12:42:22

The three biggest losers today are TOYOTA CAETANO, SPORTING, and ZAPTEC.

Financial Asset Price Change Updated (EST)
TOYOTA CAETANO (SCT.LS) 5.05 -8.18% 2024-05-09 12:23:55
SPORTING (SCP.LS) 0.97 -8.1% 2024-05-09 12:23:50
ZAPTEC (ZAP.OL) 11.79 -6.87% 2024-05-09 12:44:29
LAVIDE HOLDING (LVIDE.AS) 0.28 -6.12% 2024-05-09 12:02:44
ARGENX SE (ARGX.BR) 347.50 -5.47% 2024-05-09 12:04:47
ATLANTIC SAPPHIRE (ASA.OL) 1.05 -5.4% 2024-05-09 12:24:38
NEL (NEL.OL) 5.33 -5.2% 2024-05-09 12:41:20
PROSAFE (PRS.OL) 36.65 -4.68% 2024-05-09 12:42:20
AIB GROUP PLC (A5G.IR) 4.90 -4.28% 2024-05-09 12:22:08
ADOCIA (ADOC.PA) 8.64 -4% 2024-05-09 12:44:58

Winners today

1. NAPATECH (NAPA.OL)

28.95% Price Change

Napatech A/S offers reconfigurable computing solutions for the networking and cybersecurity applications worldwide. The company provides Link Capture Software that enables packet capture with nanosecond timestamping and replay with precise inter-frame gap control; Link Inline Software, which offers a processing architecture that offloads and accelerates flow aware application data planes; Link Virtualization Software that offloads and accelerates the Open vSwitch data plane to enhance CPU efficiency and network performance; and Link Programmable, which enables end users and OEMs to deploy FPGA computation solutions. It offers solutions for telecom operators, cloud and data center service providers, and infrastructure and defense, as well as financial services, cyber security, network management, and virtualization. Napatech A/S was incorporated in 2003 and is based in Copenhagen, Denmark.

Oslo Børs Benchmark Index_GI ended the session with NAPATECH rising 28.95% to €29.40 on Thursday while Oslo Børs Benchmark Index_GI jumped 0.3% to €1,398.27.

Earnings Per Share

As for profitability, NAPATECH has a trailing twelve months EPS of kr-0.56.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -32.02%.

Yearly Top and Bottom Value

NAPATECH’s stock is valued at kr29.40 at 22:40 EST, way below its 52-week high of kr33.00 and way higher than its 52-week low of kr8.70.

Revenue Growth

Year-on-year quarterly revenue growth grew by 71.2%, now sitting on 182.67M for the twelve trailing months.

Moving Average

NAPATECH’s worth is way above its 50-day moving average of kr21.02 and way above its 200-day moving average of kr14.48.

Volatility

NAPATECH’s last week, last month’s, and last quarter’s current intraday variation average was 0.65%, 1.24%, and 3.44%.

NAPATECH’s highest amplitude of average volatility was 13.82% (last week), 6.60% (last month), and 3.44% (last quarter).

More news about NAPATECH.

2. MOLTEN VENTURES (GRW.IR)

14.19% Price Change

ISEQ All Share ended the session with MOLTEN VENTURES jumping 14.19% to €3.38 on Thursday while ISEQ All Share dropped 2% to €9,959.71.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.34%.

Yearly Top and Bottom Value

MOLTEN VENTURES’s stock is valued at €3.38 at 22:40 EST, way below its 52-week high of €4.70 and way above its 52-week low of €2.44.

Moving Average

MOLTEN VENTURES’s value is way above its 50-day moving average of €3.01 and way above its 200-day moving average of €2.96.

More news about MOLTEN VENTURES.

3. HEXAGON COMPOSITES (HEX.OL)

12.37% Price Change

Hexagon Composites ASA, together with its subsidiaries, engages in the manufacture and sale of composite pressure cylinders and fuel systems for alternative fuels worldwide. The company operates through Hexagon Agility, Hexagon Ragasco, and Hexagon Digital Wave segments. The Hexagon Agility segment provides clean fuel solutions for commercial vehicles, passenger vehicles, and gaseous energy transportation; and gas distribution solutions. The Hexagon Ragasco segment manufacturers composite liquefied petroleum gas (LPG) cylinders for leisure, household, and industrial applications. The Hexagon Digital Wave segment offers cylinder testing and monitoring technology solutions that reduce cylinder and system down-time and inspection costs while improving inspection accuracy. Hexagon Composites ASA was founded in 1985 and is headquartered in Ålesund, Norway.

Oslo Børs Benchmark Index_GI ended the session with HEXAGON COMPOSITES rising 12.37% to €21.35 on Thursday while Oslo Børs Benchmark Index_GI jumped 0.3% to €1,398.27.

Earnings Per Share

As for profitability, HEXAGON COMPOSITES has a trailing twelve months EPS of kr-4.69.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.17%.

Volume

Today’s last reported volume for HEXAGON COMPOSITES is 2283770 which is 348.51% above its average volume of 509185.

Yearly Top and Bottom Value

HEXAGON COMPOSITES’s stock is valued at kr21.35 at 22:40 EST, way below its 52-week high of kr38.56 and way higher than its 52-week low of kr16.30.

More news about HEXAGON COMPOSITES.

4. ODFJELL SER. B (ODFB.OL)

9.24% Price Change

Odfjell SE provides services for the transportation and storage of bulk liquid chemicals, acids, edible oils, and other specialty products in North America, South America, Norway, the Netherlands, rest of Europe, the Middle East, Asia, Africa, and Australasia. The company operates through Chemical Tankers and Tank Terminals segments. It owns and operates chemical tankers that offer global and regional transportation; and tank terminals, which provide storage of various chemical and petroleum products. As of December 31, 2023, it operated a chemical tanker fleet of 68 vessels, including 46 owned/leased, 5 operational bareboat, 14 time chartered, and 3 pool vessels. The company's terminal network consists of 459 tanks with 1.3 million cubic meters of storage capacity. Odfjell SE was incorporated in 1914 and is headquartered in Bergen, Norway.

Oslo Børs Benchmark Index_GI ended the session with ODFJELL SER. B jumping 9.24% to €165.50 on Thursday while Oslo Børs Benchmark Index_GI rose 0.3% to €1,398.27.

Earnings Per Share

As for profitability, ODFJELL SER. B has a trailing twelve months EPS of kr27.85.

PE Ratio

ODFJELL SER. B has a trailing twelve months price to earnings ratio of 5.94. Meaning, the purchaser of the share is investing kr5.94 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.18%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ODFJELL SER. B’s stock is considered to be oversold (<=20).

Revenue Growth

Year-on-year quarterly revenue growth declined by 6.9%, now sitting on 1.19B for the twelve trailing months.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Feb 13, 2024, the estimated forward annual dividend rate is 13.25 and the estimated forward annual dividend yield is 8.92%.

More news about ODFJELL SER. B.

5. ODFJELL TECHNOLOGY (OTL.OL)

7.26% Price Change

Odfjell Technology Ltd., a technology and engineering company, provides well, drilling operations, and engineering services in Norway, the United Kingdom, Malaysia, Europe, Asia, and internationally. The company operates through three segments: Well Services; Operations; and Projects & Engineering. The Well Services segment provides casing and tubular running services, including automated and conventional; drilling tool and tubular rental services; and specialist well intervention products and services for exploration wells and for production. The Operations segment engages in the production of drilling and well completion on client's rigs. This segment also involves in the slot recovery, plug and abandonment, work-overs, and maintenance activities; and provision of platform drilling services on both fixed production platforms and on floating production platforms with subsea blowout preventers along with the management and performance of the services on leased Jack-up rigs, as well as rig installation services. The Projects & Engineering segment offers engineering and integrity services, including design and engineering to building supervision; and project management and operational support for units in operation, newbuild projects, and SPS/RS recertification projects and yard stays. It offers its services to the offshore oil and gas industry. The company was founded in 1973 and is headquartered in Aberdeen, the United Kingdom.

Oslo Børs Benchmark Index_GI ended the session with ODFJELL TECHNOLOGY rising 7.26% to €65.00 on Thursday while Oslo Børs Benchmark Index_GI rose 0.3% to €1,398.27.

Earnings Per Share

As for profitability, ODFJELL TECHNOLOGY has a trailing twelve months EPS of kr8.53.

PE Ratio

ODFJELL TECHNOLOGY has a trailing twelve months price to earnings ratio of 7.62. Meaning, the purchaser of the share is investing kr7.62 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 37.1%.

Yearly Top and Bottom Value

ODFJELL TECHNOLOGY’s stock is valued at kr65.00 at 22:40 EST, under its 52-week high of kr67.00 and way above its 52-week low of kr39.70.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Feb 23, 2024, the estimated forward annual dividend rate is 2.53 and the estimated forward annual dividend yield is 4.18%.

More news about ODFJELL TECHNOLOGY.

6. AFFLUENT MEDICAL (AFME.PA)

7.23% Price Change

Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.

CAC 40 ended the session with AFFLUENT MEDICAL jumping 7.23% to €1.78 on Thursday while CAC 40 rose 0.69% to €8,187.65.

Earnings Per Share

As for profitability, AFFLUENT MEDICAL has a trailing twelve months EPS of €-0.54.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.37%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AFFLUENT MEDICAL’s stock is considered to be oversold (<=20).

Volatility

AFFLUENT MEDICAL’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.57%, a negative 0.88%, and a positive 3.65%.

AFFLUENT MEDICAL’s highest amplitude of average volatility was 3.07% (last week), 2.04% (last month), and 3.65% (last quarter).

Moving Average

AFFLUENT MEDICAL’s worth is way above its 50-day moving average of €1.31 and way higher than its 200-day moving average of €1.23.

Revenue Growth

Year-on-year quarterly revenue growth declined by 16.3%, now sitting on 1.22M for the twelve trailing months.

More news about AFFLUENT MEDICAL.

7. POLIGHT (PLT.OL)

6.75% Price Change

poLight ASA develops optical lens for consumer devices and industrial applications in Europe, Asia, and the United States. The company's lens replicates the lens of the human eye enabling the implementation of autofocus functions for various applications. Its product portfolio includes TLens, a tuneable optical lens for autofocus camera applications; Packaged TLens that facilitates integration of a TLens on a fixed-focus camera module; ASIC drivers, which control the supply of variable voltage to Tlens products and makes them to change focus; TLens Silver and TLens Silver Premium devices; and evaluation kits that allows to test and evaluate the optical and electrical performance of the TLens in new products and/or applications. it serves smartphones and wearables, barcode/industrial, augmented reality, medical endoscopy, webcams, and other markets. poLight ASA was founded in 2005 and is headquartered in Skoppum, Norway.

Oslo Børs Benchmark Index_GI ended the session with POLIGHT rising 6.75% to €2.61 on Thursday while Oslo Børs Benchmark Index_GI rose 0.3% to €1,398.27.

Earnings Per Share

As for profitability, POLIGHT has a trailing twelve months EPS of kr-1.19.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.82%.

Moving Average

POLIGHT’s value is way under its 50-day moving average of kr4.87 and way under its 200-day moving average of kr12.27.

Volatility

POLIGHT’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.65%, a positive 0.86%, and a positive 6.72%.

POLIGHT’s highest amplitude of average volatility was 4.03% (last week), 5.55% (last month), and 6.72% (last quarter).

More news about POLIGHT.

8. IEP INVEST (IEP.BR)

6.54% Price Change

Iep Invest, NV is an investment firm specializing in investments in and loans to real estate companies. The firm previously operated as manufacturing group. It was formerly known as Punch International nv and changed its name to Iep Invest, NV in May 2014. Iep Invest, NV was founded in 1982 and is based in Antwerp, Belgium.

BEL 20 ended the session with IEP INVEST jumping 6.54% to €5.70 on Thursday, after five successive sessions in a row of losses. BEL 20 dropped 0.75% to €3,985.40, after five successive sessions in a row of gains, on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, IEP INVEST has a trailing twelve months EPS of €0.24.

PE Ratio

IEP INVEST has a trailing twelve months price to earnings ratio of 23.75. Meaning, the purchaser of the share is investing €23.75 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.7%.

Volatility

IEP INVEST’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.78%, a negative 0.50%, and a positive 1.52%.

IEP INVEST’s highest amplitude of average volatility was 2.78% (last week), 1.47% (last month), and 1.52% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, IEP INVEST’s stock is considered to be overbought (>=80).

More news about IEP INVEST.

9. DNO (DNO.OL)

6.38% Price Change

DNO ASA engages in the exploration, development, and production of oil and gas assets in the Middle East, the North Sea, and West Africa. The company holds 75% operating interests in the Tawke and Peshkabir fields, and 64% operating interests in the e Baeshiqa license located in the Kurdistan region of Iraq; has production licenses across 10 fields Norway and two fields in the United Kingdom; and operating interests in the producing Block CI-27, as well as operates the exploration Block CI-12 in West Africa. DNO ASA was founded in 1971 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with DNO jumping 6.38% to €11.17 on Thursday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 0.3% to €1,398.27, after four successive sessions in a row of gains, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, DNO has a trailing twelve months EPS of kr0.22.

PE Ratio

DNO has a trailing twelve months price to earnings ratio of 50.77. Meaning, the purchaser of the share is investing kr50.77 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.33%.

Volume

Today’s last reported volume for DNO is 9700690 which is 302.22% above its average volume of 2411780.

More news about DNO.

10. PROTECTOR FORSIKRG (PROT.OL)

5.92% Price Change

Protector Forsikring ASA, operates as a non-life insurance company, provides various insurance products to the commercial and public sectors, and the grouped insurance schemes markets in Norway, Denmark, Sweden, the United Kingdom, and Finland. It operates in Commercial Lines of Business and Public Lines of Business segments. The company offers personal insurance, including personal and collective accident, critical illness, group life, health, and travel insurance; motor insurance; property insurance; and liability insurance. It sells its products through insurance brokers and agents. Protector Forsikring ASA was founded in 2003 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with PROTECTOR FORSIKRG rising 5.92% to €241.50 on Thursday while Oslo Børs Benchmark Index_GI jumped 0.3% to €1,398.27.

Earnings Per Share

As for profitability, PROTECTOR FORSIKRG has a trailing twelve months EPS of kr16.23.

PE Ratio

PROTECTOR FORSIKRG has a trailing twelve months price to earnings ratio of 14.88. Meaning, the purchaser of the share is investing kr14.88 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.15%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 63% and 3385.7%, respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, PROTECTOR FORSIKRG’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for PROTECTOR FORSIKRG is 121866 which is 88.03% above its average volume of 64810.

Volatility

PROTECTOR FORSIKRG’s last week, last month’s, and last quarter’s current intraday variation average was 2.10%, 0.25%, and 1.28%.

PROTECTOR FORSIKRG’s highest amplitude of average volatility was 2.44% (last week), 1.73% (last month), and 1.28% (last quarter).

More news about PROTECTOR FORSIKRG.

Losers Today

1. TOYOTA CAETANO (SCT.LS)

-8.18% Price Change

Toyota Caetano Portugal, S.A. imports, assembles, and commercializes light and heavy vehicles. It offers commercial and passenger cars, as well as parts; cargo handling machines; and mini-buses. The company also sells and rents industrial equipment, including counterweight forklift trucks and warehouse equipment; provides technical after-sales assistance; incorporates components into commercial vehicles; and offers business services and solutions, such as short-term rental, used and reconditioned assistance, maintenance contracts sale of parts, and fleet management of related equipment. It distributes its products under the Toyota and Lexus brand names in Portugal, Belgium, African countries, Spain, Germany, the United Kingdom, and internationally. The company was incorporated in 1946 and is headquartered in Vila Nova de Gaia, Portugal. Toyota Caetano Portugal, S.A. is a subsidiary of Salvador Caetano Auto (S.G.P.S.), S.A.

PSI ended the session with TOYOTA CAETANO sliding 8.18% to €5.05 on Thursday while PSI rose 1.59% to €6,833.23.

Earnings Per Share

As for profitability, TOYOTA CAETANO has a trailing twelve months EPS of €0.5.

PE Ratio

TOYOTA CAETANO has a trailing twelve months price to earnings ratio of 10.1. Meaning, the purchaser of the share is investing €10.1 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.52%.

More news about TOYOTA CAETANO.

2. SPORTING (SCP.LS)

-8.1% Price Change

Sporting Clube de Portugal – Futebol, SAD operates sports clubs in Portugal. The company also engages in the sale of tickets for games; advertising and sponsorships activities; and provision of television rights. Sporting Clube de Portugal – Futebol, SAD was founded in 1907 and is headquartered in Lisbon, Portugal.

PSI ended the session with SPORTING sliding 8.1% to €0.97 on Thursday, following the last session’s upward trend. PSI rose 1.59% to €6,833.23, after five consecutive sessions in a row of gains, on what was an all-around up trend exchanging session today.

Earnings Per Share

As for profitability, SPORTING has a trailing twelve months EPS of €0.18.

PE Ratio

SPORTING has a trailing twelve months price to earnings ratio of 5.36. Meaning, the purchaser of the share is investing €5.36 for every euro of annual earnings.

Volatility

SPORTING’s last week, last month’s, and last quarter’s current intraday variation average was 0.32%, 0.39%, and 4.35%.

SPORTING’s highest amplitude of average volatility was 3.65% (last week), 3.36% (last month), and 4.35% (last quarter).

Volume

Today’s last reported volume for SPORTING is 1676 which is 31.03% above its average volume of 1279.

Yearly Top and Bottom Value

SPORTING’s stock is valued at €0.97 at 22:40 EST, higher than its 52-week high of €0.95.

More news about SPORTING.

3. ZAPTEC (ZAP.OL)

-6.87% Price Change

Zaptec ASA engages in the development and sale of chargers, charging systems, and services for electric car charging in Norway, Sweden, Switzerland, Denmark, Iceland, rest of Europe, and internationally. It offers Zaptec Go and Zaptec Pro alternating current walls charging station for indoor and outdoor use; Zaptec Portal, a cloud platform that monitors, balances, and optimizes the load between charging stations, while displaying real-time power usage; and Zaptec Sense for automatically adjusting the charging speed in the buildings. The company also offers accessories, including covers, charging cables, cable holders, RFID tags, and load balancers. Zaptec ASA was incorporated in 2012 and is headquartered in Stavanger, Norway.

Oslo Børs Benchmark Index_GI ended the session with ZAPTEC falling 6.87% to €11.79 on Thursday while Oslo Børs Benchmark Index_GI rose 0.3% to €1,398.27.

Earnings Per Share

As for profitability, ZAPTEC has a trailing twelve months EPS of kr0.26.

PE Ratio

ZAPTEC has a trailing twelve months price to earnings ratio of 45.35. Meaning, the purchaser of the share is investing kr45.35 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.37%.

Sales Growth

ZAPTEC’s sales growth is 7.7% for the current quarter and 29.4% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ZAPTEC’s stock is considered to be overbought (>=80).

Volatility

ZAPTEC’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.28%, a negative 1.33%, and a positive 2.56%.

ZAPTEC’s highest amplitude of average volatility was 3.33% (last week), 2.15% (last month), and 2.56% (last quarter).

More news about ZAPTEC.

4. LAVIDE HOLDING (LVIDE.AS)

-6.12% Price Change

Lavide Holding N.V. does not have significant operations. Previously, it was engaged in the provision of integrated information technology solutions for medium to large-sized companies and organizations. The company was formerly known as Qurius N.V. and changed its name to Lavide Holding N.V. in July 2013. Lavide Holding N.V. is based in Amsterdam, the Netherlands.

AEX-Index ended the session with LAVIDE HOLDING sliding 6.12% to €0.28 on Thursday, following the last session’s upward trend. AEX-Index jumped 0.51% to €904.21, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, LAVIDE HOLDING has a trailing twelve months EPS of €-0.02.

More news about LAVIDE HOLDING.

5. ARGENX SE (ARGX.BR)

-5.47% Price Change

argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, Japan, Europe, Middle East, Africa, and China. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, generalized myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, thyroid eye disease, bullous pemphigoid, myositis, primary sjögren's syndrome, post-covid postural orthostatic tachycardia syndrome, membranous nephropathy, lupus nephropathy, anca-associated vasculitis, and antibody mediated rejection; ENHANZE SC; Empasiprubart for multifocal motor neuropath, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome and amyotrophic lateral sclerosis. The company is developing ARGX-213 targets FcRn; ARGX-121 and ARGX-220 targets immune system; ARGX-109 targets IL-6; ARGX-118 for inflammation; and ARGX-109, as well as cusatuzumab, ARGX-112, ARGX-114, and ARGX-115. It owns VYVGART; VYVGART HYTRULO; VYVDURA; ARGENX; ABDEG; NHANCE; SIMPLE ANTIBODY; and ARGENXMEDHUB. The company has strategic partnership with AbbVie S.À.R.L., Zai Lab Limited, and LEO Pharma A/S; and collaboration and license agreement with Genor Biopharma Co. Ltd, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., and Shire International GmbH. It has collaboration agreement with Genmab A/S to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology, as well as a strategic collaboration with IQVIA Holdings Inc. to provide safety systems and services. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.

BEL 20 ended the session with ARGENX SE sliding 5.47% to €347.50 on Thursday, after three sequential sessions in a row of gains. BEL 20 dropped 0.75% to €3,985.40, after five sequential sessions in a row of gains, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, ARGENX SE has a trailing twelve months EPS of €-4.82.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ARGENX SE’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for ARGENX SE is 82195 which is 45.08% above its average volume of 56654.

More news about ARGENX SE.

6. ATLANTIC SAPPHIRE (ASA.OL)

-5.4% Price Change

Atlantic Sapphire ASA, together with its subsidiaries, engages in the production and sale of land-based salmon in Denmark and the United States. The company was incorporated in 2010 and is headquartered in Vikebukt, Norway.

Oslo Børs Benchmark Index_GI ended the session with ATLANTIC SAPPHIRE dropping 5.4% to €1.05 on Thursday while Oslo Børs Benchmark Index_GI jumped 0.3% to €1,398.27.

Earnings Per Share

As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-3.79.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

More news about ATLANTIC SAPPHIRE.

7. NEL (NEL.OL)

-5.2% Price Change

Nel ASA, a hydrogen company, provides various solutions to produce, store, and distribute hydrogen from renewable energy in Norway and internationally. The company operates in two segments, Nel Hydrogen Fueling and Nel Hydrogen Electrolyser. The Nel Hydrogen Fueling segment manufactures hydrogen fueling stations for fuel cell electric vehicles, such as cars, buses, trucks, and other on-road vehicles. The Nel Hydrogen Electrolyser segment supplies hydrogen production equipment based on alkaline and proton exchange membrane water electrolysis technology. It serves industries, energy, and gas companies. The company was formerly known as DiaGenic ASA and changed its name to Nel ASA in October 2014. Nel ASA was founded in 1927 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with NEL dropping 5.2% to €5.33 on Thursday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI rose 0.3% to €1,398.27, after four consecutive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, NEL has a trailing twelve months EPS of kr-0.41.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.47%.

More news about NEL.

8. PROSAFE (PRS.OL)

-4.68% Price Change

Prosafe SE, together with its subsidiaries, owns and operates semi-submersible accommodation vessels in South America, north America, and Europe. It is also involved in the maintenance and modification of installations on fields for the production, hook-up and commissioning of new fields, tiebacks to existing infrastructure, and decommissioning activities. The company owns and operates a fleet of six semi-submersible accommodation vessels and one tender support vessel. It primarily serves oil and gas industries. Prosafe SE was founded in 1972 and is headquartered in Stavanger, Norway.

Oslo Børs Benchmark Index_GI ended the session with PROSAFE dropping 4.68% to €36.65 on Thursday while Oslo Børs Benchmark Index_GI jumped 0.3% to €1,398.27.

Earnings Per Share

As for profitability, PROSAFE has a trailing twelve months EPS of kr-65.02.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -190.72%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 29.2%, now sitting on 96M for the twelve trailing months.

Yearly Top and Bottom Value

PROSAFE’s stock is valued at kr36.65 at 22:40 EST, way below its 52-week high of kr121.79 and higher than its 52-week low of kr35.40.

More news about PROSAFE.

9. AIB GROUP PLC (A5G.IR)

-4.28% Price Change

AIB Group plc provides banking and financial products and services to retail, business, and corporate customers in the Republic of Ireland and the United Kingdom. It operates through Retail Banking, AIB Capital Markets, and AIB UK, and Group segments. The company offers current and savings accounts, demand deposits, notice deposits, fixed term deposits, junior/student saver deposits, and currency deposits. It also provides personal, car, home improvement, education, business, farm development, startup, farm investment, future growth, and brexit loans; graduate, corporate, asset, energy efficiency, forestry, invoice, prompt pay and insurance premium, debt, real estate, and trade finance; business and farmer credit line, government credit guarantees, and overdrafts; and venture capital funds, as well as mortgages. In addition, the company offers credit and debit cards; investment funds; life, home, car, travel, and business succession insurance products; and pension products. Further, it provides payment, merchant, cash management, FX rates, foreign currency and interest rate risk management, exporting, international cash flow management, foreign exchange, and interest rate fluctuation management services; and trade finance products, such as documentary collections, import and export letter of credit, standby letter of credit, and bank guarantees. The company was formerly known as Allied Irish Banks, p.l.c. and changed its name to AIB Group plc in December 2017. AIB Group plc was founded in 1825 and is headquartered in Dublin, Ireland.

ISEQ All Share ended the session with AIB GROUP PLC dropping 4.28% to €4.90 on Thursday, following the last session’s downward trend. ISEQ All Share slid 2% to €9,959.71, after four consecutive sessions in a row of gains, on what was an all-around bearish trend trading session today.

Earnings Per Share

As for profitability, AIB GROUP PLC has a trailing twelve months EPS of €0.76.

PE Ratio

AIB GROUP PLC has a trailing twelve months price to earnings ratio of 6.44. Meaning, the purchaser of the share is investing €6.44 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.06%.

More news about AIB GROUP PLC.

10. ADOCIA (ADOC.PA)

-4% Price Change

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; BioChaperone LisPram, a combination of prandial insulin with pramlintide; and BioChaperone Glucagon, an aqueous formulation of human glucagon for the treatment of hypoglycemia, as well as M1Pram, a metabolite of insulin glargine and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and BioChaperone GluExe, a combination of glucagon and exenatide. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.

CAC 40 ended the session with ADOCIA sliding 4% to €8.64 on Thursday, after two successive sessions in a row of gains. CAC 40 rose 0.69% to €8,187.65, after four successive sessions in a row of gains, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, ADOCIA has a trailing twelve months EPS of €-1.9.

Volatility

ADOCIA’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.75%, a negative 0.33%, and a positive 2.85%.

ADOCIA’s highest amplitude of average volatility was 2.35% (last week), 2.22% (last month), and 2.85% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ADOCIA’s stock is considered to be oversold (<=20).

Revenue Growth

Year-on-year quarterly revenue growth declined by 62.6%, now sitting on 10.84M for the twelve trailing months.

Yearly Top and Bottom Value

ADOCIA’s stock is valued at €8.64 at 22:40 EST, way under its 52-week high of €16.16 and way higher than its 52-week low of €2.74.

More news about ADOCIA.

Stay up to date with our winners and losers daily report

Leave a Reply

Your email address will not be published. Required fields are marked *